The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Philip Morris International Update on Its Medicago Inc. Holding

Thursday, October 28, 2010

Philip Morris International Update on Its Medicago Inc. Holding11:28 EDT Thursday, October 28, 2010 NEW YORK (Business Wire) -- Philip Morris International Inc. (NYSE / Euronext Paris: PM) announces that following the expiry on October 20, 2010 of 45,000,000 common share purchase warrants of Medicago Inc. (“Medicago”) held by Philip Morris Participations B.V. (PMP) a wholly owned indirect subsidiary of PMI, the current holding of PMP in Medicago now consists of 45,000,000 common shares. This represents 32.86% of the issued and outstanding common shares of Medicago, when calculated on a non-fully diluted basis. Based on Medicago's most recent notification of the total number of common shares issued and outstanding PMI remains the largest shareholder. PMP acquired the common shares of Medicago in October 2008 pursuant to a subscription agreement. The acquisition was made in support of PMI's R & D objectives. PMP may, subject to market conditions and in accordance with applicable securities laws, make additional investments in or dispositions of securities of Medicago, including additional purchases of Medicago common shares. Philip Morris International Inc. Profile Philip Morris International Inc. (PMI) is the leading international tobacco company, with seven of the world's top 15 brands, including Marlboro, the number one cigarette brand worldwide. PMI's products are sold in approximately 160 countries. In 2009, the company held an estimated 15.4% share of the total international cigarette market outside of the U.S., or 26.0% excluding the People's Republic of China and the U.S. For more information, see Philip Morris International Inc.Investor Relations:New York: +1 (917) 663 2233Lausanne: +41 (0)58 242 4666orMedia:Lausanne: +41 (0)58 242 4500